VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-30

Study Completion Date

2015-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to test a protocol that uses clinical pictures, confocal reflectance microscopy images and dermoscopic information in a telemedicine platform. This protocol will test the technologies and diagnostic performance of dermoscopy and confocal reflectance microscopy in a randomized prospective multicenter study in five different centers in Europe.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

NCT00785369

Skin Cancer Melanoma Lentigo Maligna

COMPLETED NA

In Vivo Imaging of Pigmentary Disorders by Reflectance Confocal Microscopy

NCT00771355

Vitiligo Melasma Hyperpigmentation +1 more

TERMINATED

Photodynamic Therapy in the Treatment of Acne

NCT00613444

Acne Vulgaris

WITHDRAWN NA

Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions

NCT03565146

Pigmentation

COMPLETED NA

Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma

NCT05036200

Telangiectasia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In vivo confocal reflectance microscopy (CRM) is a non-invasive method for the in vivo (without cutting into the skik) examination of skin tumors. CRM produces cellular images with resolution comparable to histopathology. The procedure is painless, takes about ten minutes and has no documented side effects. Studies performed in the past decade have correlated CRM features in benign (non-cancerous) and malignant (cancerous) skin lesions such as moles and melanomas, as well as features of inflammatory lesions (such as allergic skin reactions) to histopathology.

Dermoscopy is a complementary technique that has been proven to be superior to the naked eye for the diagnosis of melanoma as well as some non-melanocytic skin tumors. Recently, correlation of dermoscopic and CRM structures has focused interest in the research in different groups that show that both are complementary and render in combination a better understanding of skin disease.

In this study, patients from several research centers in Europe, with lesions suspicious for malignancy and scheduled for biopsy will be asked if they would like to participate in the study. If they consent to the study, first, a clinical photograph will be taken of the lesion. Second, a dermoscopic image will be taken of the lesion, and third, CRM images will be taken of the lesion. Finally, the biopsy will be performed as per the standard of care. The images will be sent over a secure, private internet connection to physicians specially trained in the interpretation of dermoscopic and CRM images. An electronic report will be completed and returned to the Study Coordinator, who will correlate the results with the histopathologic diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Cancer Skin Lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Skin Cancer

Patients from dermatology practices throughout Europe that have a skin lesion or tumor requiring a biopsy for diagnosis.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any skin tumor considered suspicious for malignancy under clinical non-aided examination
* Histopathologic study of the tumor or short term follow up (3 months) to confirm benignity
* Clinical information and images available
* Adequate imaging by dermoscopy and CRM according to the protocol of the study
* Consent form signed by the patient

Exclusion Criteria

* Lesions with ulcerations obscuring more than 75% of the confocal mosaic field of view.
* Lesions with clinically appreciable scar.
* Lesions in locations not amenable to imaging with the confocal microscope.

Minimum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes